Why is amyloid-β PET requested after performing CSF biomarkers?
author
Reimand, Juhan
Groot, Colin
Teunissen, Charlotte E.
Windhorst, Albert D.
Boellaard, Ronald
Barkhof, Frederike
Nazarenko, Sergei
van der Flier, Wiesje M.
Scheltens, Philip
Ossenkoppele, Rik
Bouwman, Femke
statement of authorship
Reimand, Juhan, Groot, Colin, Teunissen, Charlotte E., Windhorst, Albert D., Boellaard, Ronald, Barkhof, Frederike, Nazarenko, Sergei, van der Flier, Wiesje M., van Berckel, Bart N.M., Scheltens, Philip, Ossenkoppele, Rik, Bouwman, Femke
source
Journal of Alzheimer's disease
publisher
IOS Press
journal volume number month
vol. 73, 2
year of publication
2020
pages
p. 559-569
url
https://doi.org/10.3233/JAD-190836
subject term
Alzheimeri tõbi
amüloid
tserebrospinaalvedelik
positronemissioontomograafia
neurodegeneratiivsed haigused
keyword
Alzheimer’s disease
amyloid
cerebrospinal fluid
positron emission tomography
tau proteins
ISSN
1387-2877
notes
Bibliogr.: 32 ref
Open Access
Open Access
scientific publication
teaduspublikatsioon
classifier
1.1
Scopus
Journal metrics at Scopus
Article at Scopus
WOS
Journal metrics at WOS
Article at WOS
category (general)
Psychology
en
Psühholoogia
et
Medicine
en
Meditsiin
et
Neuroscience
en
Neuroteadus
et
category (sub)
Psychology. Clinical psychology
en
Psühholoogia. Kliiniline psühholoogia
et
Medicine. Psychiatry and mental health
en
Meditsiin. Psühhiaatria ja vaimne tervis
et
Medicine. Geriatrics and gerontology
en
Meditsiin. Geriaatria ja gerontoloogia
et
Neuroscience. General neuroscience
en
Neuroteadus. Üldine neuroteadus
et
kvartiil
Q2
TTÜ department
tervisetehnoloogiate instituut
language
inglise
Uurimisrühm
Research group on diagnostics and treatment technologies of hypertension and atherosclerosis